Effectiveness and tolerability of second‐line therapy with vildagliptin vs. other oral agents in type 2 diabetes: A real‐life worldwide observational study (<scp>EDGE</scp>)
Crossref DOI link: https://doi.org/10.1111/ijcp.12252
Published Online: 2013-08-21
Published Print: 2013-10
Update policy: https://doi.org/10.1002/crossmark_policy
Mathieu, C.
Barnett, A. H.
Brath, H.
Conget, I.
Castro, J. J.
Göke, R.
Márquez Rodriguez, E.
Nilsson, P. M.
Pagkalos, E.
Penfornis, A.
Schaper, N.C.
Wangnoo, S. K.
Kothny, W.
Bader, G.
Version of Record valid from 2013-08-21
Text and Data Mining valid from 2013-08-21
Text and Data Mining valid from 2015-09-01
Publication History